China's National Medical Products Administration approves the use of the neutralizing antibody cocktail developed by BRII Biosciences to treat COVID-19 in adults and teenagers. (Financial Post) COVID-19 pandemic in mainland China, COVID-19 drug developmentCOVID-19 pandemic in AsiaCOVID-19 pandemic link embed save